1. Introduction {#s0005}
===============

Myotonic dystrophy type 1 (DM1), also known as Steinert\'s myotonic dystrophy, is the most frequent inherited adult dystrophic myopathy due to a nucleotide expansion (CTG) in the DMPK gene mapped on chromosome 19q13.3 ([@bb0270]). Studies regarding the pathogenetic mechanism hypothesized an accumulation of CUG-CCUG-containing transcripts within cell nuclei as ribonuclear inclusions that provoke the deregulation of numerous RNA binding factors, leading to a dysregulation of alternative splicing of several genes encoding for proteins and channels fundamental for muscle and Central Nervous System (CNS) activity ([@bb0175]). This hypothesis is also supported by neuropathological findings and indeed the presence of CUG-containing RNA has been reported in DM1 cortical-subcortical neurons ([@bb0175]). Moreover, neurofibrillary degeneration with intraneuronal hyperphosphorilated Tau proteins has been reported in DM1 brain specimens ([@bb0220], [@bb0175]).

Disease onset is typically in the adult age and muscle weakness, myotonia, and cataracts represent the main clinical features, although the disease may frequently affect other organs and systems. In particular, CNS involvement, characterized by mood and personality alterations, cognitive impairment, sleep disturbances, is quite common during disease course ([@bb0270], [@bb0040]). Previous conventional studies of magnetic resonance imaging (MRI) showed diffuse brain alterations in DM1 patients such as lateral ventricle dilatation, cortical and subcortical gray matter atrophy and leukodystrophy, prevalent in the anterior temporal lobes ([@bb0040]).

In the last decade, advanced MRI studies demonstrated across brain a widespread white matter disruption and a multifocal gray matter volume loss by using various single MRI techniques, including Diffusion Tensor Imaging (DTI), and Voxel-Based Morphometry (VBM), with correlations found between corresponding quantitative MRI parameters and triplet expansion, neuropsychological tests and the severity of muscular involvement ([@bb0015], [@bb0105], [@bb0190], [@bb0285], [@bb0180], [@bb0300], [@bb0090], [@bb0305], [@bb0050], [@bb0310], [@bb0225], [@bb0215]).

The aim of our study was to evaluate the extent of white and gray matter alterations in the brain of patients with DM1 compared to healthy controls by using multimodal voxel-wise methods, such as TBSS, VBM and vertex-based cortical thickness (CT) analysis, and therefore to highlight possible correlations of these quantitative MRI measures with clinical and genetic data.

2. Materials and methods {#s0010}
========================

2.1. Subjects {#s0015}
-------------

We enrolled 24 genetically confirmed DM1 patients (14 males; age \[mean ± SD\]: 38.5 ± 11.8 years; age at onset: 22.3 ± 12.8 years, range: 0--53 years; disease duration: 16.2 ± 10.8 years, range: 1--36 years) and 25 age- and sex-matched healthy controls (14 males; age: 38.5 ± 11.3 years). Demographic and clinical features of patients and controls are reported in [Table 1](#t0005){ref-type="table"}.

Patients were enrolled at the neuromuscular outpatients unit of the U.O. Clinica Neurologica, IRCCS Istituto delle Scienze Neurologiche di Bologna, by neurologists expert in neuromuscular disorders (RoL). Controls, matched to patients for age and sex, were selected among a sample of healthy volunteers, enrolled among University and Hospital workers and their relatives, that underwent brain MRI in order to obtain normative values for quantitative MRI parameters for clinical and research purposes.

Clinical diagnosis was genetically confirmed and CTG triplet expansion sizes were determined in all patients. Depending on the number of repeat expansions, patients were divided into classes E1 (mild phenotype, 50--150 CTG repeats), E2 (adult classical form, 150--1000 CTG repeats) or E3 (congenital disease, more than CTG 1000 repeats) ([@bb0060]).

An extensive neurological examination and a disability scale for DM1 created by Contardi and colleagues, investigating neuropsychological (maximum score = 20), motor (maximum score = 35), myotonia (maximum score = 12) and daily life activity (maximum score = 15) areas were performed in all patients, with a total score ranging from 0 (normal) to 82 (worst condition) ([@bb0060]).

Moreover, all patients underwent a neuropsychological assessment including Mini Mental State Examination (MMSE) ([@bb0085], [@bb0170]), Wechsler Adult Intelligence Scale (WAIS) 3rd edition ([@bb0290]) with Verbal Intelligence score (VIQ) and non-verbal performance score (PIQ), Brief Mental Deterioration Battery (BMDB) ([@bb0095]) including Rey\'s 15 word test, Immediate Visual Memory (IVM) test, Barrage Test (BT) and simple analogies (SA) test, Verbal Fluency test ([@bb0185]), Stroop Test ([@bb0250]) and Wisconsin Card Sorting Test (WCST) ([@bb0160]). All the tests scores were normalized by correction for age and education.

2.2. Brain MRI acquisition and analysis protocol {#s0020}
------------------------------------------------

MRI scans were acquired on a 1.5-T GE Signa scanner equipped with a quadrature birdcage head coil.

All patients and controls underwent a standardized brain MRI protocol including the following sequences: a 3D high-resolution T1-weighted fast spoiled gradient echo (FSPGR; TR = 12 ms, TE = 5 ms, 1 mm isotropic resolution), an axial T2-weighted fluid-attenuated inversion recovery (FLAIR; TE = 84.8 ms, TR = 8000 ms, 0.9375 mm in-plane resolution, 3 mm slice thickness) and, finally, DTI (TR = 10.000 ms, TE = 87.5 ms, 25 directions, b-value = 900 mm^2^ s^− 1^, axial oblique FOV = 32 cm, 1.25 mm reconstructed in-plane resolution, 4 mm slices thickness).

2.3. White matter lesions segmentation and filling {#s0025}
--------------------------------------------------

In order to quantify patients\' white matter lesion load, a semi-automatized threshold-based segmentation of white matter lesions has been performed on T2-weighted FLAIR images by using Jim software (Version 7.0, Xinapse Systems, Northants, UK, <http://www.xinapse.com>).

For each subject T2-weighted FLAIR images were co-registered onto T1-weighted 3D images FLIRT ([@bb0145], [@bb0150]), part of the Oxford FMRIB Software Library \[FSL\], [www.fmrib.ox.ac.uk](http://www.fmrib.ox.ac.uk){#ir0010} ([@bb0240]) using the boundary-based registration (BBR) method and the transformation matrix was used to register the lesion map onto the T1-weighted 3D images, applying a nearest-neighbor interpolation method to keep the mask intact during spatial transformation ([@bb0115]). In order to improve the accuracy of brain volume measurements thereafter by reducing intensity contrast within known lesion areas, the FSL lesion filling tool ([@bb0020]) was applied to the T1-weighted 3D images using the co-registered lesion masks.

2.4. TBSS analysis {#s0030}
------------------

DTI data underwent standard pre-processing and processing, all of them performed with FMRIB Diffusion Toolbox (FDT part of FSL) ([@bb0025]). In particular, DTI images were corrected for movements and distortions caused by eddy currents with a linear registration to non-diffusion volumes. After brain extraction (BET, Brain Extraction Tool) ([@bb0230]), a voxel-by-voxel fitting of diffusion tensor model using *dtifit* was performed, in order to obtain maps of fractional anisotropy (FA), axial diffusivity (AD), radial diffusivity (RD) and mean diffusivity.

Voxelwise statistical analysis of the FA data was carried out using TBSS (Tract-Based Spatial Statistics) ([@bb0245]), also part of FSL. All subjects\' FA data were aligned into a common space using the nonlinear registration tool FNIRT ([@bb0005], [@bb0010]), which uses a b-spline representation of the registration warp field ([@bb0210]). Next, the mean FA image was created and thinned to create a mean FA skeleton, which represents the centers of all tracts common to the group. Each subject\'s aligned FA data was then projected onto this skeleton and the resulting data fed into voxelwise cross-subject statistics. FA skeleton was created by using a threshold at a value of 0.2 to exclude voxels with low FA values, which are likely to include gray matter or cerebrospinal fluid (CSF). Voxelwise statistical analysis was performed on AD, RD and MD data as well, by using the transformations and the template previously obtained for FA data.

2.5. Voxel-based morphometry analysis {#s0035}
-------------------------------------

All the gray matter structural analyses were performed on the T1-weighted 3D images after lesion filling.

Structural data was analyzed with FSL-VBM ([@bb0075]), an optimized VBM protocol ([@bb0110]) carried out with FSL tools. First, structural images were brain-extracted and gray matter-segmented before being registered onto the MNI 152 standard space using non-linear registration ([@bb0010]). The resulting images were averaged and flipped along the x-axis to create a left-right symmetric, study-specific gray matter template. Second, all native gray matter images were non-linearly registered to this study-specific template and "modulated" to correct for local expansion (or contraction) due to the non-linear component of the spatial transformation. The modulated gray matter images were then smoothed with an isotropic Gaussian kernel with a sigma of 3 mm (corresponding to a FWHM of about 7 mm).

2.6. Cortical thickness analysis {#s0040}
--------------------------------

Cortical reconstruction and cortical thickness measurement were performed with the FreeSurfer 4.4.0 image analysis suite, and a detailed description of preprocessing and processing is available at <http://surfer.nmr.mgh.harvard.edu>/. Concisely, after skull-stripping and intensity correction, the gray-white matter boundary for each cortical hemisphere (with tissue intensity and neighborhood constraints) was identified. Then the surface boundary was tessellated to generate multiple vertices across the whole brain, and inflated. The expansion of the resulting gray matter surface created the pial surface with a point-to-point correspondence, and spherical morphing and spherical registration to an atlas were performed. Cortical thickness was computed by using the methods developed by Fishl and Dale ([@bb0080]). Cortical maps were finally smoothed with a 10-mm FWHM Gaussian kernel.

2.7. Statistical analysis {#s0045}
-------------------------

We performed a Spearman correlation test in order to evaluate the correlation between white matter lesion volume, Total Intracranial Volume (TIV)-corrected lateral ventricle volume and clinical-genetic variables.

For both TBSS and VBM analyses, a voxel-wise General Linear Model (GLM) was applied to compare DM1 group and healthy controls group by using the FSL\'s tool (*randomise*) for nonparametric permutation inference on neuroimaging data ([@bb0295]), performing 5000 permutations. Results were corrected for multiple comparisons across space, controlling the family-wise error (FWE) and applying TFCE (threshold-free cluster enhancement) ([@bb0235]). TBSS comparisons were performed within a white matter skeletonized mask (obtained during TBSS processing stream), and VBM comparisons were performed within a gray matter mask (obtained during FSL-VBM processing). The same method was applied to perform voxel-wise correlations with clinical variables.

Vertex-by-vertex multiple linear regression analysis (surface equivalent of voxel-wise analysis) was carried out to compare CT in DM1 patients and healthy controls, and to investigate the relationship between regional CT and clinical-genetic variables, including neuropsychological tests (corrected MMSE score, VIQ, PIQ and WAIS total score, BMDB final result and the corrected results of its subtests, Verbal Fluency test corrected score, reaction time at Stroop test, WCST scores (perseverative responses, non-perseverative errors, categories completed, learning to learn, global score)). Statistical maps were generated using FreeSurfer\'s QDEC 1.5 (Query, Design, Estimate, Contrast) interface. Analysis was performed over the whole brain surface and Monte Carlo simulation was conducted to correct for multiple comparisons on the significant clusters, using a cluster-wise threshold of p \< 0.05. As for nuisance regressors, age and sex were added for TBSS analysis, while age, sex and total intracranial volume (TIV), using estimated TIV from the Freesurfer processing stream, were added for VBM and CT analysis.

Comparisons were also performed with a homogeneous sub-sample of DM1 patients constituted only by the classical and juvenile DM1 cases (n = 17, age (mean ± SD) 39.3 ± 12.5 years, 10 M), i.e. excluding congenital cases (E3, n = 7), compared to a sub-group of age- and sex-matched healthy controls (n = 17, age (mean ± SD) 39.3 ± 12.4 years, 10 M).

3. Results {#s0050}
==========

3.1. Clinical and genetic features {#s0055}
----------------------------------

All patients, except one, who was without motor impairment, presented muscular symptoms including myotonia (23/24 patients) and muscle weakness (21/24 patients).

As regards genetic classification of patients, 4 belonged to E1, 13 to E2 and 7 to E3 classes. Mean (± standard deviation - SD) education of cases was 10.0 ± 2.8 years. The results of the sub-sections of the clinical scale \[median (range)\] were 3 (0--16) for the neuropsychological area, 11 (0--23) for the motor area, 7 (0--12) for the myotonia area, 2.5 (0--9) for the daily-life activities area with a median (range) total score of 23 (1--59) ([Table 1](#t0005){ref-type="table"}).

In three patients out of 24, full neuropsychological evaluation was not performed: two patients refused to undergo neuropsychological testing while one patient\'s general conditions were too poor to allow the neuropsychological assessment. Among the other 21 cases, corrected MMSE score (mean ± SD) was 27.0 ± 2.7 with 2 cases with a score lower than 23 (both belonging to the E3 category); final result of BMDB scale was 1.6 ± 0.9 with no patients displaying pathological results (\< 0), and total IQ score was 81.6 ± 20.6, with 8 patients with a score between 50 and 79 ([Table 1](#t0005){ref-type="table"}), with five belonging to E3 and two to E2 category. The results of the other neuropsychological tests are reported in [Table 1](#t0005){ref-type="table"}.

Overall, our DM1 subjects demonstrated no significant memory deficits, while the scores of the test investigating executive functions, i.e. reasoning ability and shifting cognitive strategies (WCST), and a mean total IQ score were at the lower limits of the normal range. Additionally, motor impairment did not systematically interfere with test performance in our sample, as can be seen from the results showing a lower performance in the test exploring cognitive domains not related to motor ability (i.e., WCST), and from the absence of evident discrepancies between IQ verbal and performance scores.

3.2. Conventional brain MRI {#s0060}
---------------------------

No patients or controls were excluded from the analysis because of a suboptimal quality of T2-, T1-weighted and DTI sequences. Eleven patients out of 24 showed mild to moderate cortical atrophy and/or mild to severe lateral ventricle enlargement. Five out of 24 DM1 patients and all control subjects showed no white matter signal alterations at conventional brain MRI, while the other 19 showed supratentorial white matter T2-hyperintensities with a mean lesion load of 17. 2 ± 27.5 cm^3^. In the 19 DM1 patients with white matter lesions, we found a direct correlation between white matter lesion load and age at evaluation (r = 0.644, p = 0.003) and an inverse correlation with corrected MMSE score (r = − 0.487, p = 0.48).

The correlation analysis between TIV-corrected lateral ventricle volume and clinical, neuropsychological and genetic features failed to yield significant results, after Bonferroni correction for multiple comparisons.

3.3. TBSS {#s0065}
---------

White matter voxel-wise comparison performed by using TBSS showed a widespread significant lower FA and higher MD, AD and RD in patients compared to controls (p \< 0.05, corrected) ([Fig. 1](#f0005){ref-type="fig"} and supplementary Tables 1.1--1.4). The TBSS analysis including only cases in categories E1 and E2 led to similar results (supplementary Figure 1).

The analysis of the correlations among MRI-derived white matter integrity parameters and clinical-genetic features demonstrated a significant correlation between MMSE corrected score and DTI metrics in the splenium and the posterior part of the body of the corpus callosum (CC), posterior corona radiata and posterior thalamic radiations, bilaterally and the right retrolenticular part of the internal capsule (p \< 0.05, corrected) ([Fig. 2](#f0010){ref-type="fig"} and supplementary Table 2.1).

As regards the clinical scale, all DTI metrics in the CC (genu, body and splenium), supero-posterior corona radiata, posterior thalamic radiations, external capsule and superior longitudinal fasciculus correlated with neuropsychological, motor, myotonia areas and with the total score (p \< 0.05, corrected) ([Fig. 2](#f0010){ref-type="fig"} and supplementary Tables 2.2--2.5). No correlations were found between DTI metrics and daily life activities area. Moreover, we found a correlation between triplet expansion size and white matter DTI parameters, diffuse to all white matter tracts in supra- and infratentorial compartments (p \< 0.05, corrected) ([Fig. 2](#f0010){ref-type="fig"} and supplementary Table 2.6). We found no correlation between DTI metrics and the other neuropsychological tests. No correlation with clinical, neuropsychological or genetic data and white matter disruption was found when considering E1 and E2 cases alone.

3.4. VBM {#s0070}
--------

Compared to healthy controls, patients presented a bilateral significant smaller gray matter quantity in subcortical regions such as thalamus, hippocampus, putamen and caudate, and in cingulate, frontal, parietal, occipital, insular and temporal cortices (p \< 0.05, corrected) ([Fig. 3](#f0015){ref-type="fig"} and supplementary Tables 3.1--3.3). Considering patients within genetic categories E1 and E2, VBM analysis showed a comparable atrophy of subcortical gray matter, while cortical gray matter atrophy was of smaller extent (supplementary Figure 2).

We found no significant correlations of VBM results with clinical-genetic data.

3.5. Cortical thickness {#s0075}
-----------------------

Compared to controls, DM1 patients presented a significant lower CT in lateral-occipital cortex bilaterally, in the right precentral and in the left superior-parietal, superior-temporal and fusiform cortices (p \< 0.05, corrected) ([Fig. 4](#f0020){ref-type="fig"} and supplementary Table 4). The analysis performed on E1 and E2 cases only showed a smaller cortical thickness differences compared to controls, restricted to portions of the left fusiform, lingual and inferior temporal gyri (supplementary Fig. 3).

No significant correlations between CT and clinical-genetic variables were found.

4. Discussion {#s0080}
=============

Diffuse brain white and gray matter alterations in 24 adult DM1 patients were found on conventional brain MRI and voxel-wise MRI data analysis methods.

Nineteen out of 24 patients presented the neuroimaging hallmarks of DM1, i.e. multiple T2-hyperintense white matter lesions associated with different degrees of lateral ventricle enlargement, ranging from mild to severe. Our conventional imaging data are consistent with previous studies showing brain alterations in DM1 ([@bb0015], [@bb0105], [@bb0190], [@bb0285], [@bb0180], [@bb0300], [@bb0090], [@bb0305], [@bb0050], [@bb0310], [@bb0225]), although, compared to previous studies that quantified white matter lesion load ([@bb0015], [@bb0050], [@bb0225]), our patients presented a more severe white matter involvement, in absence of overall significant cognitive deficits.

Moreover, we found a correlation between white matter lesion load, age at evaluation and MMSE corrected score. In addition, previous studies demonstrated a significant correlation between white matter lesion load and clinical and genetic data ([@bb0050], [@bb0225]), indicating that its quantification plays a fundamental role in order to better characterize the patient sample and to increase voxel-wise analysis accuracy.

In addition, we confirmed a significant correlation among white and gray matter disruption, assessed by TBSS, VBM and CT analysis, global motor and cognitive functioning, and triplet expansion size.

Although previous studies evaluated gray and white matter integrity in patients with DM1 by using VBM and TBSS, and demonstrated a correlation with clinical and genetic data ([@bb0180], [@bb0050], [@bb0225], [@bb0215]), our study is the first in which both a CT analysis and a VBM approach have been applied to the same group of DM1 in order to better investigate the different contribution of CT alterations and global gray matter density.

Moreover, to our knowledge, this is the first study in patients with DM1 that applies a semi-automatic lesion refilling method before performing both VBM and CT analysis, while a previous study applied a fully automated lesion refilling pipeline to VBM in DM1 and DM2 patients ([@bb0215]). It has been demonstrated that lesion refilling in patients with diffuse white matter alterations increases accuracy of VBM analysis ([@bb0055]). The comparison between DM1 patients and controls showed a diffuse disruption of white matter with a correlation with genetic severity, i.e. triplet expansion.

In addition, in order to evaluate if diffuse brain white and gray matter alterations could influence clinical disability, we investigated the correlation between TBSS, CT analysis and VBM results and global motor and cognitive functioning measured by a clinical scale investigating neuropsychological, motor, myotonic symptoms and daily life activities ([@bb0060]) and MMSE, a scale that is widely used to assess global cognitive functioning.

To our knowledge, no volumetric MR studies investigated the association between myotonia severity and brain alterations. Only one fMRI study investigated CNS correlates of myotonia in 16 patients with DM1. It was found a bigger BOLD signal in the supplementary motor area and in the dorsal anterior cingulate cortex during myotonia phase, suggesting a role of high-order motor control areas in the genesis of this phenomenon ([@bb0265]). Interestingly, in our sample the severity of myotonia correlated with a diffuse white matter alteration involving also the posterior limb of the internal capsule, the corona radiata adjacent to motor areas and the splenium CC ([Fig. 2](#f0010){ref-type="fig"}). White matter differences in the same regions correlated also with the "motor area" score of the clinical scale ([Fig. 2](#f0010){ref-type="fig"}).

In addition, cognitive performance, assessed by MMSE and the neuropsychological area of the clinical scale, showed a correlation with callosal alterations, in particular in the posterior part of the body, isthmus and splenium.

The results of our VBM analysis showed diffuse gray matter alterations in DM1 patients compared to controls, involving subcortical and cortical regions belonging to all lobes, while CT analysis showed a prevalent involvement of parietal-occipital regions. As previously reported, VBM analysis returns a general and mixed measure of gray matter volume, which combines different structural properties, such as CT, surface area and cortical folding ([@bb0125]). However, these properties are essentially independent from each other. CT analysis offers a direct examination of a physical property of the cortex, providing information about the morphometric characteristics of the cortex. Nevertheless, CT analysis is necessarily constrained to the cortex, while VBM can be used to detect differences in sub-cortical gray matter as well. It is advantageous to combine these two techniques considering the complementary nature of the two methods, in order to obtain more comprehensive information about brain structure. The analyses of both CT and VBM have been simultaneously applied to the same sample of subjects in normal aging ([@bb0130]) and other neurologic and psychiatric diseases, such as psychosis ([@bb0030]), schizophrenia ([@bb0200]), Parkinson\'s disease ([@bb0205]), Alzheimer\'s disease ([@bb0165]), major depressive disorder ([@bb0155]), autism ([@bb0135]), and, overall, consistent results between the two techniques were observed, gaining complementary information about patterns of brain atrophy.

Taking into account these considerations, the interpretation of our results regarding cortical gray matter integrity may be that a smaller CT in DM1 plays a predominant role in parietal-occipital regions, while in frontal and temporal cortices other features, such as surface area and cortical folding, may be responsible for the alterations detected by VBM analysis.

The alterations in posterior associative fibers, i.e. splenium of CC, posterior thalamic radiations, posterior part of corona radiata, and in the parietal-occipital gray matter in which a decrease of gray matter volume due principally to CT was evident in our sample, are significantly correlated to a worse motor and cognitive performance, and may explain cognitive deficits and personality alterations that are generally described in DM1 patients. Previous studies in DM1 patients found an association between cognitive performance and posterior associative fibers. In particular, posterior callosal fibers, that are more resistant to damage because they myelinate early during brain development, are related to cognitive dysfunction ([@bb0070]). Moreover callosal alterations have been related to personality alterations, possible due to an altered hemispheric integration ([@bb0275]).

We also confirmed smaller subcortical gray matter volume, in particular of hippocampus, thalamus and striate nucleus, compared to controls. Previous neuropathological and neuroimaging studies detected alterations in the basal ganglia and hippocampus ([@bb0280], [@bb0190], [@bb0195], [@bb0140], [@bb0285], [@bb0180], [@bb0050]). These regions are involved in motor control and cognitive functioning and their alterations may contribute to the development of CNS involvement signs.

Notably, we found a correlation between clinical and genetic features with white matter disruption but not with gray matter alterations. The clinical relevance of white matter disruption has been seen in other previous studies on DM1 ([@bb0180], [@bb0050]) and are suggestive of a primarily white matter involvement in DM1 with a secondary gray matter involvement. These hypotheses are also supported by the results obtained after the exclusion of cases with more severe genetic lesions (E3), showing white matter and subcortical gray matter alterations with milder cortical alterations. Moreover, the association between white matter alterations and global cognitive performance, observed when considering all genetic categories, was no longer significant after the exclusion of E3 class. This finding is in line with a previous study indicating that cognitive performance is related to callosal alterations only in the congenital cases ([@bb0120]). A study by Giorgio and colleagues, however, showed diffuse atrophy of the neocortex in DM1 patients without or with minimal white matter alterations ([@bb0105]). One limitation of the study is represented by the higher educational level of controls compared to patients that may partially explain the differences in brain structure. Although our results showed a lower performance in a test exploring cognitive domains that are not related to motor ability (i.e., WCST) and no discrepancies between IQ verbal and performance scores were evident, the performance of some tests included in the neuropsychological battery, such as Stroop test, may be affected by motor impairment, and therefore, this potential confounder has to be taken into account when interpreting the results.

In addition, our study may present some technical limitations, due to the fact that the data were collected within a typical clinical framework: lesion filling is restricted to lesions larger that 3 mm along the z direction; diffusion weighted images are characterized by low spatial resolution and non isotropic voxels; the intensity of the static magnetic field is relatively low (1.5 T). Despite these limitations, we believe that our evaluation of both white matter and gray matter integrity in the same cohort of DM1 patients, correlated with clinical and genetic aspects, is robust and the results provide an insight into the physiopathology of the disease.

5. Conclusions {#s0085}
==============

DM1 is a multisystemic disorder in which CNS involvement, correlated with clinical and genetic severity, is characterized by diffuse alterations extending to all white matter tracts in supra- and infratentorial compartments, as demonstrated by TBSS analysis, and to cortical-subcortical gray matter, as evidenced by VBM and cortical thickness analysis. Globally, our results indicate the complexity of CNS involvement in DM1 and further longitudinal studies are needed to clarify it.

Appendix A. Supplementary data {#s0095}
==============================

Supplementary materialImage 1

Supplementary data to this article can be found online at [http://dx.doi.org/10.1016/j.nicl.2016.04.012](10.1016/j.nicl.2016.04.012){#ir0020}.

![Tract-based spatial statistics (TBSS) group comparison results, displayed at p \< 0.05 corrected for multiple comparisons. Voxel-wise differences between myotonic dystrophy type 1 (DM1) patients and healthy controls (HC) are shown for fractional anisotropy (FA; in red, decreased in patients), mean diffusivity (MD; in blue, higher in patients), axial diffusivity (AD; in yellow, higher in patients) and radial diffusivity (RD; in violet, higher in patients) values. All statistical maps are overlaid on the group mean FA image and on the white matter skeleton mask (green). Images are shown in radiological convention. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)](gr1){#f0005}

![Tract-based spatial statistics (TBSS) correlations results, displayed at p \< 0.05 corrected for multiple comparisons. Voxel-wise correlations between fractional anisotropy (FA) values and clinical variables in myotonic dystrophy type 1 (DM1) patients are shown in red. The correlations are all inverse, except for FA - MMSE which showed a direct correlation. All statistical maps (with tracts thickened for visualization purposes) are overlaid on the group mean FA image and on the white matter skeleton mask (green). Images are shown in radiological convention.\
Legend. MMSE: Mini-Mental State Examination; NP: neuropsychological. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)](gr2){#f0010}

![Voxel-based morphometry (VBM) group comparison results displayed at p \< 0.05 corrected for multiple comparisons. Voxel-wise differences between myotonic dystrophy type 1 (DM1) patients and healthy controls are displayed with (1-p) values in red-to-white. Areas of gray matter atrophy are overlaid on the group gray matter template and shown in radiological convention. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)](gr3){#f0015}

![Group comparison results of cortical thickness (CT) analysis displayed at p \< 0.05, corrected for multiple comparisons. Whole brain vertex-wise differences of cortical thickness between myotonic dystrophy type 1 (DM1) patients and healthy controls are displayed with − log10(p) values. Areas of gray matter thinning are overlaid on a reference gray matter surface; left hemisphere is shown on right and right hemisphere on left; lateral view on top and medial view at bottom.](gr4){#f0020}

###### 

Demographic and clinical features of study sample.

Table 1

                                                   Myotonic dystrophy 1 patients (n = 24)   Controls (n = 25)   p
  ------------------------------------------------ ---------------------------------------- ------------------- ------
  Age (years) (mean ± SD)                          38.5 ± 11.8                              38.5 ± 11.3         n.s.
  Sex (M)                                          14                                       14                  n.s.
  Age at onset (years) \[mean ± SD (range)\]       22.3 ± 12.8 (0--53)                                          
  Disease duration (years) \[mean ± SD (range)\]   16.2 ± 10.8 (1--36)                                          
  Education (years) (mean ± SD)                    10.0 ± 2.8                                                   
  CTG triplet expansion size category                                                                           
   E1                                              4                                                            
   E2                                              13                                                           
   E3                                              7                                                            
  Clinical scale scores \[median (range)\]                                                                      
   Neuropsychological area                         3 (0--16)                                                    
   Motor area                                      11 (0−23)                                                    
   Myotonia area                                   7 (0−12)                                                     
   Daily-life activities area                      2.5 (0--9)                                                   
   Total score                                     23 (1--59)                                                   
                                                                                                                

  Neuropsychological evaluation           N    Score (mean ± SD)   Normal values cut offs         \% of patients with pathological scores
  --------------------------------------- ---- ------------------- ------------------------------ -----------------------------------------
  Corrected MMSE score                    21   27.0 ± 2.7          \> 23.8 [@bb0170]              9.5%
  BMDB final result                       20   1.6 ± 0.9           \> 0 [@bb0095], [@bb0100]      0%
   - Rey\'s 15 word test (short term)     20   45.8 ± 8.9           \>28.53 [@bb0045]             0%
   - Rey\'s 15 word test (long term)      20   9.8 ± 2.3           \> 4.69 [@bb0045]              0%
   - Immediate Visual Memory test         20   17.9 ± 3.0          \> 13.85 [@bb0045]             10.0%
   - Barrage Test                         20   11.0 ± 2.0          \> 9 [@bb0045]                 10.0%
   - Simple analogies                     20   16.4 ± 2.6          \> 15.1 [@bb0095], [@bb0100]   20.0%
  Total WAIS score                        17   81.6 ± 20.6          \> 70 [@bb0290]               29.4%
   - Verbal Intelligence score            17   83.9 ± 18.8         \> 70 ([@bb0290])              29.4%
   - Non-verbal performance score         17   82.9 ± 19.8         \> 70 [@bb0290]                29.4%
  Verbal Fluency test                     20   33.4 ± 12.8         \> 17.35 [@bb0045]             10.0%
  Stroop Test (reaction time - seconds)   20   30.4 ± 22.5         \< 36.91 [@bb0035]             20.0%
  Wisconsin Card Sorting Test             19                                                      
   - Corrected perseverative responses    19   23.8 ± 29.7         \< 42.60 [@bb0160]             15.8%
   - Corrected non-perseverative errors   19   18.3 ± 16.8         \< 29.90 [@bb0160]             26.3%
   - Categories completed                 19   4.2 ± 2             No cut-off                     
   - Learning to learn                    19   − 0.6 ± 5.7          \>0.00 [@bb0260]              50.0%
   - Corrected total score                19   67.4 ± 40.1          \<90.50 [@bb0160]             36.8%

Legend. SD: standard deviation; M: males; MMSE: Mini Mental State Examination; BMDB: Brief Mental Deterioration Battery; WAIS: Wechsler Adult Intelligence Scale -- 3rd edition; WCST: Wisconsin Card Sorting Test.

[^1]: Contributed equally.
